MANAGING CRITICAL ILL COVID IN ICU.ppt
•Download as PPT, PDF•
0 likes•3 views
This document discusses the management of critically ill COVID patients in the ICU. It defines critical illness as patients admitted to the ICU. It notes that COVID patients treated in the Ampang Hospital ICU had high severity scores (SAPS II of 43.7 and SOFA of 7.4) and mortality rates of 34.1-43.5%. The document outlines guidelines for managing COVID-19 induced ARDS, including protective lung strategies using low tidal volumes, recruitment maneuvers, ventilator strategies like APRV and ECMO, and supportive strategies like prone positioning, sedation, and conservative fluid therapy. Close monitoring of oxygenation, ventilation, hemodynamics, and hydration is emphasized.
Report
Share
Report
Share
Recommended
2 Updated COVID 19 introduction V21.pptx
This document provides information on the 2019 novel coronavirus (COVID-19) outbreak, including that it originated from Wuhan, China in December 2019 and is transmitted between humans. It causes respiratory illness with common symptoms like fever, cough and fatigue. While most cases are mild, management involves early detection, infection control measures, and supportive care like oxygen therapy for severe cases.
Corona virus
This document summarizes information about COVID-19, including that it originated from a bat coronavirus and has now spread to over 160 countries, with over 246,000 confirmed cases and 10,000 deaths as of March 2020. It is the third documented coronavirus to spread from animals to humans, after SARS in 2002 and MERS in 2012. COVID-19 is caused by SARS-CoV-2 virus and common symptoms include fever, dry cough, and fatigue, though 80% of cases are mild. Diagnosis involves RT-PCR testing of respiratory samples, and prevention requires investments in laboratory resources and clinical networks.
Novel corona virus
This document provides information about the novel coronavirus (2019-nCoV) that was first detected in Wuhan, China in late 2019. It discusses the virus's origins, symptoms, transmission, incubation period, treatment and prevention. Key points include that the virus causes respiratory illness and in rare cases can be lethal, has an incubation period of 2-14 days, spreads through respiratory droplets, and treatment involves supportive care while a vaccine is not yet available. The summary provides high-level essential details about the virus in a concise manner.
Covid 19-book
The document provides guidelines for COVID-19 surveillance and response in Punjab, Pakistan. It outlines case definitions, epidemiology of COVID-19, alert thresholds, and surveillance protocols. It describes laboratory diagnosis, contact tracing, and the roles and responsibilities of the Provincial Disease Surveillance and Response Unit. Guidelines are provided for clinical management, laboratory sample collection and transport, and infection prevention and control.
The Outbreak of COVID 19 An Overview
Corona viruses are a group of RNA viruses. In late December 2019, Patients with pneumonia with unknown etiology was get admitted in health care facilities in Wuhan, China, and resulted in a pandemic disease which affected more than 200 countries and responsible for 182,989 deaths world wide. The disease is officially named as Coronavirus Disease 2019 COVID 19, by WHO on February 11, 2020 . COVID 19 is a potential zoonotic disease with low to moderate estimated 2 -5 mortality rate. Currently, there is no definite treatment for COVID 19 although some trials are under investigation. Hence, appropriate use of PPE, regular hand hygiene, Respiratory and cough etiquettes, social distancing are some key elements to prevent the spread of disease. Ms. Pabalpreet Kaur | Ms. Eenu | Ms. Pooja Jaswal | Dr. (Mrs.) Jyoti Sarin "The Outbreak of COVID-19: An Overview" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-4 , June 2020, URL: https://www.ijtsrd.com/papers/ijtsrd30859.pdf Paper Url :https://www.ijtsrd.com/medicine/nursing/30859/the-outbreak-of-covid19-an-overview/ms-pabalpreet-kaur
Introduction to covid 19
Detailed description about COVID-19 is given along with structure,transmission, symptoms & 4Cs of WHO.
Coronavirus presentation
This document provides an overview of COVID-19, including its aetiology, epidemiology, clinical features, diagnosis, management, and prevention. It describes how COVID-19 is caused by a novel coronavirus, SARS-CoV-2, which likely originated in animals. It summarizes the symptoms of COVID-19 and outlines recommendations for preventing and treating both mild and severe cases. The document also discusses differential diagnoses and provides references for further information.
Corona Virus Basic Introduction
The document provides information about Coronavirus (COVID-19). It describes how COVID-19 is caused by SARS-CoV-2 virus and spreads mainly through respiratory droplets from infected individuals. Common symptoms include fever, cough and shortness of breath. While most cases are mild, it can progress to pneumonia and multi-organ failure in some cases. The mortality rate is around 2%. Currently there is no vaccine, though some antiviral medications are being tested. Prevention relies on hand washing and hygiene measures.
Recommended
2 Updated COVID 19 introduction V21.pptx
This document provides information on the 2019 novel coronavirus (COVID-19) outbreak, including that it originated from Wuhan, China in December 2019 and is transmitted between humans. It causes respiratory illness with common symptoms like fever, cough and fatigue. While most cases are mild, management involves early detection, infection control measures, and supportive care like oxygen therapy for severe cases.
Corona virus
This document summarizes information about COVID-19, including that it originated from a bat coronavirus and has now spread to over 160 countries, with over 246,000 confirmed cases and 10,000 deaths as of March 2020. It is the third documented coronavirus to spread from animals to humans, after SARS in 2002 and MERS in 2012. COVID-19 is caused by SARS-CoV-2 virus and common symptoms include fever, dry cough, and fatigue, though 80% of cases are mild. Diagnosis involves RT-PCR testing of respiratory samples, and prevention requires investments in laboratory resources and clinical networks.
Novel corona virus
This document provides information about the novel coronavirus (2019-nCoV) that was first detected in Wuhan, China in late 2019. It discusses the virus's origins, symptoms, transmission, incubation period, treatment and prevention. Key points include that the virus causes respiratory illness and in rare cases can be lethal, has an incubation period of 2-14 days, spreads through respiratory droplets, and treatment involves supportive care while a vaccine is not yet available. The summary provides high-level essential details about the virus in a concise manner.
Covid 19-book
The document provides guidelines for COVID-19 surveillance and response in Punjab, Pakistan. It outlines case definitions, epidemiology of COVID-19, alert thresholds, and surveillance protocols. It describes laboratory diagnosis, contact tracing, and the roles and responsibilities of the Provincial Disease Surveillance and Response Unit. Guidelines are provided for clinical management, laboratory sample collection and transport, and infection prevention and control.
The Outbreak of COVID 19 An Overview
Corona viruses are a group of RNA viruses. In late December 2019, Patients with pneumonia with unknown etiology was get admitted in health care facilities in Wuhan, China, and resulted in a pandemic disease which affected more than 200 countries and responsible for 182,989 deaths world wide. The disease is officially named as Coronavirus Disease 2019 COVID 19, by WHO on February 11, 2020 . COVID 19 is a potential zoonotic disease with low to moderate estimated 2 -5 mortality rate. Currently, there is no definite treatment for COVID 19 although some trials are under investigation. Hence, appropriate use of PPE, regular hand hygiene, Respiratory and cough etiquettes, social distancing are some key elements to prevent the spread of disease. Ms. Pabalpreet Kaur | Ms. Eenu | Ms. Pooja Jaswal | Dr. (Mrs.) Jyoti Sarin "The Outbreak of COVID-19: An Overview" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-4 , June 2020, URL: https://www.ijtsrd.com/papers/ijtsrd30859.pdf Paper Url :https://www.ijtsrd.com/medicine/nursing/30859/the-outbreak-of-covid19-an-overview/ms-pabalpreet-kaur
Introduction to covid 19
Detailed description about COVID-19 is given along with structure,transmission, symptoms & 4Cs of WHO.
Coronavirus presentation
This document provides an overview of COVID-19, including its aetiology, epidemiology, clinical features, diagnosis, management, and prevention. It describes how COVID-19 is caused by a novel coronavirus, SARS-CoV-2, which likely originated in animals. It summarizes the symptoms of COVID-19 and outlines recommendations for preventing and treating both mild and severe cases. The document also discusses differential diagnoses and provides references for further information.
Corona Virus Basic Introduction
The document provides information about Coronavirus (COVID-19). It describes how COVID-19 is caused by SARS-CoV-2 virus and spreads mainly through respiratory droplets from infected individuals. Common symptoms include fever, cough and shortness of breath. While most cases are mild, it can progress to pneumonia and multi-organ failure in some cases. The mortality rate is around 2%. Currently there is no vaccine, though some antiviral medications are being tested. Prevention relies on hand washing and hygiene measures.
Novel corona virus (n cov 2019)
Corona viruses are a group of viruses that infect human & birds. Human corona virus is enveloped, single stranded, positive sense RNA virus. Only seven strain of corona virus are infect man, in which four are circulating in human population.
Novel corona virus 2019 (nCoV2019) is a newly identified human corona virus that has 94% similarity of SARS corona virus. The outbreak of this virus was reported to on 31 December, 2019. The WHO declared the outbreak as a public health emergence of international concern on 23 January. prevention is better than cure.
No vaccine is available.
There is no vaccine available to prevent this infection,
Presentation on COVID-19 in March 2020
The document discusses coronavirus disease 2019 (COVID-19), caused by the virus SARS-CoV-2. It covers the virus's origin in Wuhan, China in late 2019. It describes SARS-CoV-2 as being similar to the SARS virus and using the ACE2 receptor. The disease has since spread globally. Clinical features include fever, cough and pneumonia symptoms, with over 80% of cases being mild. Imaging findings include bilateral ground-glass opacities. There is no vaccine and treatment is supportive.
Corona Virus Disease - Covid 19 (nCorona Virus-2019) Update
CORONA VIRUS DISEASE ( COVID - 19 ) - Clinical profile, investigations, treatment, prevention and myths as per WHO/CDC guidelines as on FEBRUARY 2020
COVID -19 PANDEMIC + CHARMAINE NUGUID.pptx
The document discusses the COVID-19 pandemic. It describes how the virus spreads from person to person, its symptoms, and how it began in Wuhan, China in 2019. It then discusses the first cases in the Philippines in January 2020 and the economic impacts the pandemic has had in the country including high unemployment rates. The document also summarizes information on some of the first COVID-19 vaccines developed including those by Pfizer/BioNTech, Moderna, and in China and India.
Emphasis on wellness, education and prevention of covid 19
The document discusses COVID-19 and provides information on the virus, its transmission, symptoms, diagnosis, treatment and prevention. It describes coronaviruses and defines COVID-19. It covers the incidence and spread of COVID-19 globally. Key points include how the virus is transmitted, its incubation period, high-risk groups, common and severe symptoms, diagnostic tests and medical management. The presentation emphasizes the importance of prevention measures like hand washing, social distancing and mask wearing.
Diagnosis of the novel coronavirus disease 2019 (covid 19)
The document discusses the diagnosis of COVID-19. It describes that there are two primary diagnostic methods: 1) a molecular-based assay using reverse transcription-polymerase chain reaction (RT-PCR) to detect the virus's genetic material and 2) a lateral flow immunoassay to detect antibodies against the virus. RT-PCR is currently the most accurate laboratory method but is more expensive and complex, while lateral flow tests are cheaper, simpler, and suitable for point-of-care and home testing. Diagnostic testing is critical for monitoring the spread of the virus over time and location.
COVID SEMINAR AU.pptx
COVID is a pandemic virus which is ruled over wide continent in this slide iam following to explain overall about covid
COVID-19 Risk Assessment Perspective
The document discusses COVID-19 from a risk assessment perspective. It describes how COVID-19 spreads via droplets from coughing or sneezing and falls to the ground within a few feet. The virus is classified as a high risk due to its rapid global spread and impact on health. Older adults and those with preexisting conditions are at higher risk of serious illness. While most COVID-19 cases are mild, its case fatality ratio is estimated at 6.86%, higher than for SARS or MERS. Risk can be mitigated through measures like social distancing, increased sanitation, testing and contact tracing, and use of personal protective equipment in healthcare settings. Lessons from the COVID-19 pandemic must result in improved
Coronavirus Pandemic Part I: Overview of COVID-19 (Rev01)
Description: The COVID-19 pandemic has taken the world by storm, bringing world economies to its knees. These slides give an overview of coronaviruses, its discovery, as well as a comparison between SARS, MERS and the latest COVID-19. Slides revised to include upcoming topics.
Module 1a n cov introduction v2
This document provides an overview of the 2019 novel coronavirus (2019-nCoV) outbreak that began in Wuhan, China in December 2019. It describes the clinical presentation and management of 2019-nCoV, compares it to other coronaviruses like SARS and MERS, and outlines current WHO guidance on case definitions, investigations and infection control.
COVID 19 A Scoping Review
This article provides a review of COVID-19 (coronavirus disease 2019), the respiratory disease caused by the novel coronavirus SARS-CoV-2. It discusses the epidemiology, causes, clinical manifestations, diagnosis, and prevention/control of COVID-19. Key points include that COVID-19 symptoms can range from mild to severe/fatal, with the elderly and those with preexisting conditions most at risk of complications. Diagnosis is via PCR tests of respiratory samples. While there are no approved vaccines or treatments yet, prevention focuses on avoiding exposure, hand washing, and other hygiene/social distancing practices. The aim is to increase awareness and understanding of this ongoing public health threat.
Novel coronavirus-19
- A novel coronavirus was identified in Wuhan, China in late 2019 and caused a pneumonia outbreak. It has since spread globally resulting in the COVID-19 pandemic.
- SARS-CoV-2, the virus that causes COVID-19, is transmitted primarily through respiratory droplets. It has an incubation period of up to 14 days. Clinical features range from mild to severe/critical illness.
- Diagnosis is made through RT-PCR testing of respiratory samples. Chest CT may show signs of viral pneumonia. Management involves isolation and supportive care, with investigational antiviral treatments being explored.
COVID-19 Infection Prevention and Control (IPC)
The document provides information on the novel coronavirus (COVID-19), including that it is a new strain of coronavirus that has not previously infected humans. Coronaviruses can cause illnesses ranging from the common cold to more severe diseases like MERS and SARS. COVID-19 was first identified in Wuhan, China in December 2019. It has since spread to many other countries. The incubation period is estimated to be 1-12.5 days, with common symptoms including fever, cough, and shortness of breath. Transmission occurs via respiratory droplets from infected individuals or contact with contaminated surfaces. There is currently no vaccine available.
Coronavirus disease (covid 19)
The document discusses coronavirus disease (COVID-19) including its definition, transmission, clinical presentation, course, and diagnostic testing recommendations. It defines healthcare personnel and notes COVID-19 is a new coronavirus strain discovered in 2019 that is zoonotic, mainly spread through respiratory droplets. Symptoms can range from mild to severe and include fever, cough and shortness of breath. Older patients and those with chronic conditions are at higher risk. Diagnostic testing is recommended for suspected cases using molecular tests on respiratory specimens.
Covid-19
This document provides an overview of COVID-19 including its timeline, transmission, presentation, epidemiology, prevention, and containment plan. It discusses that COVID-19 is a respiratory infection caused by SARS-CoV-2. It outlines the timeline of the outbreak beginning in December 2019 in Wuhan, China. It also discusses transmission modes, signs and symptoms, disease progression, prevention strategies like isolation, quarantine, hand hygiene, and use of personal protective equipment.
The novel coronavirus disease 2019 (covid 19)overview
COVID-19 is a disease caused by a new strain of coronavirus. ‘CO’ stands for corona, ‘VI’ for virus, and ‘D’ for disease. Formerly, this disease was referred to as ‘2019 novel coronavirus’ or ‘2019-nCoV.’The COVID-19 virus is a new virus linked to the same family of viruses as Severe Acute Respiratory Syndrome and some types of common cold. The Coronavirus (COVID-19) was first reported in Wuhan, Hubei, China in December 2019, the outbreak was later recognized as a pandemic by the World Health Organization (WHO) on 11 March 2020. Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing, Avoid close contact with anyone.
Corona2019 what we know?
This document summarizes the current knowledge about coronavirus disease 2019 (COVID-19). It discusses that COVID-19 is caused by the virus SARS-CoV-2 which originated in bats. The main symptoms are fever, cough and difficulty breathing. The virus spreads through droplets and close contact between people. Diagnosis is done through RT-PCR testing of throat swabs. Currently there are no specific treatments, but research is being done into antiviral medications. Public health measures aim to control the spread and protect vulnerable populations.
Dethroning CORONA virus
This presentation showed the impact and the challenges of facing COVID-19 Pandemic and how the world becomes morbid, while the healthcare workforce tries to flatten the "curve".
CORONA VIRUS & it’s effect on daily life
The world is facing a challenging. An essential key to combat COVID-19 is to be educated and be familiar to the disease itself and to plan strategies that will help the world win the fight against the crisis.
Covid 19 presentation
The document provides information on SARS-CoV-2, the virus that causes COVID-19, including its origins and symptoms. It discusses NSW Health's response to an outbreak of the virus in Australia, including procedures for identifying and managing cases, infection control strategies, and guidance for healthcare workers. The document also contains technical details about the virus and disease.
一比一原版(USF毕业证)旧金山大学毕业证如何办理
USF毕业证offer【微信95270640】《旧金山大学毕业证购买》《如何办理USF毕业证旧金山大学文凭学历》Q微信95270640实体公司，专业可靠，办理毕业证办美国成绩单,做加拿大文凭学历认证,办新西兰学位证，学位证书是什么?《制作旧金山大学毕业证多少钱》《USF学历证书丢了怎么办理》办澳洲文凭认证，办留信网认证（网上可查，实体公司，专业可靠）
专业为留学生办理旧金山大学旧金山大学硕士学位证成绩单【100%存档可查】留学全套申请材料办理。本公司承诺所有毕业证成绩单成品全部按照学校原版工艺对照一比一制作和学校一样的羊皮纸张保证您证书的质量！
如果你回国在学历认证方面有以下难题请联系我们我们将竭诚为你解决认证瓶颈
1所有材料真实但资料不全无法提供完全齐整的原件。【如：成绩单丶毕业证丶回国证明等材料中有遗失的。】
2获得真实的国外最终学历学位但国外本科学历就读经历存在问题或缺陷。【如：国外本科是教育部不承认的或者是联合办学项目教育部没有备案的或者外本科没有正常毕业的。】
3学分转移联合办学等情况复杂不知道怎么整理材料的。时间紧迫自己不清楚递交流程的。
如果你是以上情况之一请联系我们我们将在第一时间内给你免费咨询相关信息。我们将帮助你整理认证所需的各种材料.帮你解决国外学历认证难题。
国外旧金山大学旧金山大学硕士学位证成绩单办理方法：
1客户提供办理信息：姓名生日专业学位毕业时间等（如信息不确定可以咨询顾问：我们有专业老师帮你查询旧金山大学旧金山大学硕士学位证成绩单）；
2开始安排制作旧金山大学毕业证成绩单电子图；
3旧金山大学毕业证成绩单电子版做好以后发送给您确认；
4旧金山大学毕业证成绩单电子版您确认信息无误之后安排制作成品；
5旧金山大学成品做好拍照或者视频给您确认；
6快递给客户（国内顺丰国外DHLUPS等快读邮寄）。头贼脑的倒也逗人喜爱日上三竿时山娃总爱窜进自家瓜棚里跟小伙伴们坐着聊天聊着聊着便忍不住往瓜田里逡巡一番抱起一只硕大的西瓜用石刀劈开抑或用拳头砸开每人抱起一大块就啃啃得满嘴满脸猴屁股般的红艳大家一个劲地指着对方吃吃地笑瓜裂得古怪奇形怪状却丝毫不影响瓜味甜丝丝的满嘴生津遍地都是瓜横七竖八的活像掷满了一地的大石块摘走二三只爷爷是断然发现不了的即便发现爷爷也不恼反而教山娃辨认孰熟孰嫩孰甜孰淡名义上是护瓜吃
Surface guided deep inspiration breath hold (SG-DIBH) in ultra-hypofractionat...
Cynthia Aristei
Professor
University of Perugia and Perugia General Hospital
Italy
More Related Content
Similar to MANAGING CRITICAL ILL COVID IN ICU.ppt
Novel corona virus (n cov 2019)
Corona viruses are a group of viruses that infect human & birds. Human corona virus is enveloped, single stranded, positive sense RNA virus. Only seven strain of corona virus are infect man, in which four are circulating in human population.
Novel corona virus 2019 (nCoV2019) is a newly identified human corona virus that has 94% similarity of SARS corona virus. The outbreak of this virus was reported to on 31 December, 2019. The WHO declared the outbreak as a public health emergence of international concern on 23 January. prevention is better than cure.
No vaccine is available.
There is no vaccine available to prevent this infection,
Presentation on COVID-19 in March 2020
The document discusses coronavirus disease 2019 (COVID-19), caused by the virus SARS-CoV-2. It covers the virus's origin in Wuhan, China in late 2019. It describes SARS-CoV-2 as being similar to the SARS virus and using the ACE2 receptor. The disease has since spread globally. Clinical features include fever, cough and pneumonia symptoms, with over 80% of cases being mild. Imaging findings include bilateral ground-glass opacities. There is no vaccine and treatment is supportive.
Corona Virus Disease - Covid 19 (nCorona Virus-2019) Update
CORONA VIRUS DISEASE ( COVID - 19 ) - Clinical profile, investigations, treatment, prevention and myths as per WHO/CDC guidelines as on FEBRUARY 2020
COVID -19 PANDEMIC + CHARMAINE NUGUID.pptx
The document discusses the COVID-19 pandemic. It describes how the virus spreads from person to person, its symptoms, and how it began in Wuhan, China in 2019. It then discusses the first cases in the Philippines in January 2020 and the economic impacts the pandemic has had in the country including high unemployment rates. The document also summarizes information on some of the first COVID-19 vaccines developed including those by Pfizer/BioNTech, Moderna, and in China and India.
Emphasis on wellness, education and prevention of covid 19
The document discusses COVID-19 and provides information on the virus, its transmission, symptoms, diagnosis, treatment and prevention. It describes coronaviruses and defines COVID-19. It covers the incidence and spread of COVID-19 globally. Key points include how the virus is transmitted, its incubation period, high-risk groups, common and severe symptoms, diagnostic tests and medical management. The presentation emphasizes the importance of prevention measures like hand washing, social distancing and mask wearing.
Diagnosis of the novel coronavirus disease 2019 (covid 19)
The document discusses the diagnosis of COVID-19. It describes that there are two primary diagnostic methods: 1) a molecular-based assay using reverse transcription-polymerase chain reaction (RT-PCR) to detect the virus's genetic material and 2) a lateral flow immunoassay to detect antibodies against the virus. RT-PCR is currently the most accurate laboratory method but is more expensive and complex, while lateral flow tests are cheaper, simpler, and suitable for point-of-care and home testing. Diagnostic testing is critical for monitoring the spread of the virus over time and location.
COVID SEMINAR AU.pptx
COVID is a pandemic virus which is ruled over wide continent in this slide iam following to explain overall about covid
COVID-19 Risk Assessment Perspective
The document discusses COVID-19 from a risk assessment perspective. It describes how COVID-19 spreads via droplets from coughing or sneezing and falls to the ground within a few feet. The virus is classified as a high risk due to its rapid global spread and impact on health. Older adults and those with preexisting conditions are at higher risk of serious illness. While most COVID-19 cases are mild, its case fatality ratio is estimated at 6.86%, higher than for SARS or MERS. Risk can be mitigated through measures like social distancing, increased sanitation, testing and contact tracing, and use of personal protective equipment in healthcare settings. Lessons from the COVID-19 pandemic must result in improved
Coronavirus Pandemic Part I: Overview of COVID-19 (Rev01)
Description: The COVID-19 pandemic has taken the world by storm, bringing world economies to its knees. These slides give an overview of coronaviruses, its discovery, as well as a comparison between SARS, MERS and the latest COVID-19. Slides revised to include upcoming topics.
Module 1a n cov introduction v2
This document provides an overview of the 2019 novel coronavirus (2019-nCoV) outbreak that began in Wuhan, China in December 2019. It describes the clinical presentation and management of 2019-nCoV, compares it to other coronaviruses like SARS and MERS, and outlines current WHO guidance on case definitions, investigations and infection control.
COVID 19 A Scoping Review
This article provides a review of COVID-19 (coronavirus disease 2019), the respiratory disease caused by the novel coronavirus SARS-CoV-2. It discusses the epidemiology, causes, clinical manifestations, diagnosis, and prevention/control of COVID-19. Key points include that COVID-19 symptoms can range from mild to severe/fatal, with the elderly and those with preexisting conditions most at risk of complications. Diagnosis is via PCR tests of respiratory samples. While there are no approved vaccines or treatments yet, prevention focuses on avoiding exposure, hand washing, and other hygiene/social distancing practices. The aim is to increase awareness and understanding of this ongoing public health threat.
Novel coronavirus-19
- A novel coronavirus was identified in Wuhan, China in late 2019 and caused a pneumonia outbreak. It has since spread globally resulting in the COVID-19 pandemic.
- SARS-CoV-2, the virus that causes COVID-19, is transmitted primarily through respiratory droplets. It has an incubation period of up to 14 days. Clinical features range from mild to severe/critical illness.
- Diagnosis is made through RT-PCR testing of respiratory samples. Chest CT may show signs of viral pneumonia. Management involves isolation and supportive care, with investigational antiviral treatments being explored.
COVID-19 Infection Prevention and Control (IPC)
The document provides information on the novel coronavirus (COVID-19), including that it is a new strain of coronavirus that has not previously infected humans. Coronaviruses can cause illnesses ranging from the common cold to more severe diseases like MERS and SARS. COVID-19 was first identified in Wuhan, China in December 2019. It has since spread to many other countries. The incubation period is estimated to be 1-12.5 days, with common symptoms including fever, cough, and shortness of breath. Transmission occurs via respiratory droplets from infected individuals or contact with contaminated surfaces. There is currently no vaccine available.
Coronavirus disease (covid 19)
The document discusses coronavirus disease (COVID-19) including its definition, transmission, clinical presentation, course, and diagnostic testing recommendations. It defines healthcare personnel and notes COVID-19 is a new coronavirus strain discovered in 2019 that is zoonotic, mainly spread through respiratory droplets. Symptoms can range from mild to severe and include fever, cough and shortness of breath. Older patients and those with chronic conditions are at higher risk. Diagnostic testing is recommended for suspected cases using molecular tests on respiratory specimens.
Covid-19
This document provides an overview of COVID-19 including its timeline, transmission, presentation, epidemiology, prevention, and containment plan. It discusses that COVID-19 is a respiratory infection caused by SARS-CoV-2. It outlines the timeline of the outbreak beginning in December 2019 in Wuhan, China. It also discusses transmission modes, signs and symptoms, disease progression, prevention strategies like isolation, quarantine, hand hygiene, and use of personal protective equipment.
The novel coronavirus disease 2019 (covid 19)overview
COVID-19 is a disease caused by a new strain of coronavirus. ‘CO’ stands for corona, ‘VI’ for virus, and ‘D’ for disease. Formerly, this disease was referred to as ‘2019 novel coronavirus’ or ‘2019-nCoV.’The COVID-19 virus is a new virus linked to the same family of viruses as Severe Acute Respiratory Syndrome and some types of common cold. The Coronavirus (COVID-19) was first reported in Wuhan, Hubei, China in December 2019, the outbreak was later recognized as a pandemic by the World Health Organization (WHO) on 11 March 2020. Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing, Avoid close contact with anyone.
Corona2019 what we know?
This document summarizes the current knowledge about coronavirus disease 2019 (COVID-19). It discusses that COVID-19 is caused by the virus SARS-CoV-2 which originated in bats. The main symptoms are fever, cough and difficulty breathing. The virus spreads through droplets and close contact between people. Diagnosis is done through RT-PCR testing of throat swabs. Currently there are no specific treatments, but research is being done into antiviral medications. Public health measures aim to control the spread and protect vulnerable populations.
Dethroning CORONA virus
This presentation showed the impact and the challenges of facing COVID-19 Pandemic and how the world becomes morbid, while the healthcare workforce tries to flatten the "curve".
CORONA VIRUS & it’s effect on daily life
The world is facing a challenging. An essential key to combat COVID-19 is to be educated and be familiar to the disease itself and to plan strategies that will help the world win the fight against the crisis.
Covid 19 presentation
The document provides information on SARS-CoV-2, the virus that causes COVID-19, including its origins and symptoms. It discusses NSW Health's response to an outbreak of the virus in Australia, including procedures for identifying and managing cases, infection control strategies, and guidance for healthcare workers. The document also contains technical details about the virus and disease.
Similar to MANAGING CRITICAL ILL COVID IN ICU.ppt (20)
Corona Virus Disease - Covid 19 (nCorona Virus-2019) Update
Corona Virus Disease - Covid 19 (nCorona Virus-2019) Update
Emphasis on wellness, education and prevention of covid 19
Emphasis on wellness, education and prevention of covid 19
Diagnosis of the novel coronavirus disease 2019 (covid 19)
Diagnosis of the novel coronavirus disease 2019 (covid 19)
Coronavirus Pandemic Part I: Overview of COVID-19 (Rev01)
Coronavirus Pandemic Part I: Overview of COVID-19 (Rev01)
The novel coronavirus disease 2019 (covid 19)overview
The novel coronavirus disease 2019 (covid 19)overview
Recently uploaded
一比一原版(USF毕业证)旧金山大学毕业证如何办理
USF毕业证offer【微信95270640】《旧金山大学毕业证购买》《如何办理USF毕业证旧金山大学文凭学历》Q微信95270640实体公司，专业可靠，办理毕业证办美国成绩单,做加拿大文凭学历认证,办新西兰学位证，学位证书是什么?《制作旧金山大学毕业证多少钱》《USF学历证书丢了怎么办理》办澳洲文凭认证，办留信网认证（网上可查，实体公司，专业可靠）
专业为留学生办理旧金山大学旧金山大学硕士学位证成绩单【100%存档可查】留学全套申请材料办理。本公司承诺所有毕业证成绩单成品全部按照学校原版工艺对照一比一制作和学校一样的羊皮纸张保证您证书的质量！
如果你回国在学历认证方面有以下难题请联系我们我们将竭诚为你解决认证瓶颈
1所有材料真实但资料不全无法提供完全齐整的原件。【如：成绩单丶毕业证丶回国证明等材料中有遗失的。】
2获得真实的国外最终学历学位但国外本科学历就读经历存在问题或缺陷。【如：国外本科是教育部不承认的或者是联合办学项目教育部没有备案的或者外本科没有正常毕业的。】
3学分转移联合办学等情况复杂不知道怎么整理材料的。时间紧迫自己不清楚递交流程的。
如果你是以上情况之一请联系我们我们将在第一时间内给你免费咨询相关信息。我们将帮助你整理认证所需的各种材料.帮你解决国外学历认证难题。
国外旧金山大学旧金山大学硕士学位证成绩单办理方法：
1客户提供办理信息：姓名生日专业学位毕业时间等（如信息不确定可以咨询顾问：我们有专业老师帮你查询旧金山大学旧金山大学硕士学位证成绩单）；
2开始安排制作旧金山大学毕业证成绩单电子图；
3旧金山大学毕业证成绩单电子版做好以后发送给您确认；
4旧金山大学毕业证成绩单电子版您确认信息无误之后安排制作成品；
5旧金山大学成品做好拍照或者视频给您确认；
6快递给客户（国内顺丰国外DHLUPS等快读邮寄）。头贼脑的倒也逗人喜爱日上三竿时山娃总爱窜进自家瓜棚里跟小伙伴们坐着聊天聊着聊着便忍不住往瓜田里逡巡一番抱起一只硕大的西瓜用石刀劈开抑或用拳头砸开每人抱起一大块就啃啃得满嘴满脸猴屁股般的红艳大家一个劲地指着对方吃吃地笑瓜裂得古怪奇形怪状却丝毫不影响瓜味甜丝丝的满嘴生津遍地都是瓜横七竖八的活像掷满了一地的大石块摘走二三只爷爷是断然发现不了的即便发现爷爷也不恼反而教山娃辨认孰熟孰嫩孰甜孰淡名义上是护瓜吃
Surface guided deep inspiration breath hold (SG-DIBH) in ultra-hypofractionat...
Cynthia Aristei
Professor
University of Perugia and Perugia General Hospital
Italy
2024 HIPAA Compliance Training Guide to the Compliance Officers
Join us for a comprehensive 90-minute lesson designed specifically for Compliance Officers and Practice/Business Managers. This 2024 HIPAA Training session will guide you through the critical steps needed to ensure your practice is fully prepared for upcoming audits. Key updates and significant changes under the Omnibus Rule will be covered, along with the latest applicable updates for 2024.
Key Areas Covered:
Texting and Email Communication: Understand the compliance requirements for electronic communication.
Encryption Standards: Learn what is necessary and what is overhyped.
Medical Messaging and Voice Data: Ensure secure handling of sensitive information.
IT Risk Factors: Identify and mitigate risks related to your IT infrastructure.
Why Attend:
Expert Instructor: Brian Tuttle, with over 20 years in Health IT and Compliance Consulting, brings invaluable experience and knowledge, including insights from over 1000 risk assessments and direct dealings with Office of Civil Rights HIPAA auditors.
Actionable Insights: Receive practical advice on preparing for audits and avoiding common mistakes.
Clarity on Compliance: Clear up misconceptions and understand the reality of HIPAA regulations.
Ensure your compliance strategy is up-to-date and effective. Enroll now and be prepared for the 2024 HIPAA audits.
Enroll Now to secure your spot in this crucial training session and ensure your HIPAA compliance is robust and audit-ready.
https://conferencepanel.com/conference/hipaa-training-for-the-compliance-officer-2024-updates
Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdf
The "Comprehensive Rainy Season Advisory: Safety and Preparedness Tips" offers essential guidance for navigating rainy weather conditions. It covers strategies for staying safe during storms, flood prevention measures, and advice on preparing for inclement weather. This advisory aims to ensure individuals are equipped with the knowledge and resources to handle the challenges of the rainy season effectively, emphasizing safety, preparedness, and resilience.
Get Covid Testing at Fit to Fly PCR Test
A Fit-to-Fly PCR Test is a crucial service for travelers needing to meet the entry requirements of various countries or airlines. This test involves a polymerase chain reaction (PCR) test for COVID-19, which is considered the gold standard for detecting active infections. At our travel clinic in Leeds, we offer fast and reliable Fit to Fly PCR testing, providing you with an official certificate verifying your negative COVID-19 status. Our process is designed for convenience and accuracy, with quick turnaround times to ensure you receive your results and certificate in time for your departure. Trust our professional and experienced medical team to help you travel safely and compliantly, giving you peace of mind for your journey.
Pneumothorax and role of Physiotherapy in it.
This particular slides consist of- what is Pneumothorax,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is a summary of Pneumothorax:
Pneumothorax, also known as a collapsed lung, is a condition that occurs when air leaks into the space between the lung and chest wall. This air buildup puts pressure on the lung, preventing it from expanding fully when you breathe. A pneumothorax can cause a complete or partial collapse of the lung.
Sheard's criterion and Percival criterion.pptx
The main theme of this presentation to share knowledge about the guidelines to prescribe prism for compensating the phoria.
CCSN_June_06 2024_jones. Cancer Rehabpptx
About this webinar: This talk will introduce what cancer rehabilitation is, where it fits into the cancer trajectory, and who can benefit from it. In addition, the current landscape of cancer rehabilitation in Canada will be discussed and the need for advocacy to increase access to this essential component of cancer care.
DRAFT Ventilator Rapid Reference version 2.4.pdf
Ventilator rapid reference for the Zoll Z cvent. Presented for educational purposes only.
Know Latest Hiranandani Hospital Powai News.pdf
As Mumbai's premier kidney transplant and donation center, L H Hiranandani Hospital Powai is not just a medical facility; it's a beacon of hope where cutting-edge science meets compassionate care, transforming lives and redefining the standards of kidney health in India.
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
Joker Wigs has been a one-stop-shop for hair products for over 26 years. We provide high-quality hair wigs, hair extensions, hair toppers, hair patch, and more for both men and women.
MYASTHENIA GRAVIS POWER POINT PRESENTATION
Myasthenia gravis is a neurological disease. It affects the grave muscles in our body. Myasthenia gravis affects how the nerves communicate with the muscles. Drooping eyelids and/or double vision are often the first noticeable sign. It is involving the muscles controlling the eyes movement, facial expression, chewing and swallowing. It also effects the muscles neck and lip movement and respiration.
It is a neuromuscular disease characterized by abnormal weakness of voluntary muscles that improved with rest and the administration of anti-cholinesterase drugs.
The person may find difficult to stand, lift objects and speak or swallow. Medications and surgery can help the patient to relieve the symptoms of this lifelong illness.
Psychedelic Retreat Portugal - Escape to Lighthouse Retreats for an unforgett...
Our aim is to organise conscious gatherings and retreats for open and inquisitive minds and souls, with and without the assistance of sacred plants.
Top Rated Massage Center In Ajman Chandrima Spa
The best massage spa Ajman is Chandrima Spa Ajman, which was founded in 2023 and is exclusively for men 24 hours a day. As of right now, our parent firm has been providing massage services to over 50,000+ clients in Ajman for the past 10 years. It has about 8+ branches. This demonstrates that Chandrima Spa Ajman is among the most reasonably priced spas in Ajman and the ideal place to unwind and rejuvenate. We provide a wide range of Spa massage treatments, including Indian, Pakistani, Kerala, Malayali, and body-to-body massages. Numerous massage techniques are available, including deep tissue, Swedish, Thai, Russian, and hot stone massages. Our massage therapists produce genuinely unique treatments that generate a revitalized sense of inner serenely by fusing modern techniques, the cleanest natural substances, and traditional holistic therapists.
Friendly Massage in Ajman - Malayali Kerala Spa Ajman
At Malayali Kerala Spa Ajman, Full Service includes individualized care for every client. We specifically design each massage session for the individual needs of the client. Our therapists are always willing to adjust the treatments based on the client's instruction and feedback. This guarantees that every client receives the treatment they expect.
By offering a variety of massage services, our Ajman Spa Massage Center can tackle physical, mental, and emotional illnesses. In addition, efficient identification of specific health conditions and designing treatment plans accordingly can significantly enhance the quality of massaging.
At Malayali Kerala Spa Ajman, we firmly believe that everyone should have the option to experience top-quality massage services regularly. To achieve that goal we offer cheap massage services in Ajman.
If you are interested in experiencing transformative massage treatment at Malayali Kerala Spa Ajman, you can use our Ajman Massage Center WhatsApp Number to schedule your next massage session.
Contact @ +971 529818279
Visit @ https://malayalikeralaspaajman.com/
Bath patient Fundamental of Nursing.pptx
This is presentation about how to bath a patient.
It is a fundamental of nursing.
Recently uploaded (20)
Surface guided deep inspiration breath hold (SG-DIBH) in ultra-hypofractionat...
Surface guided deep inspiration breath hold (SG-DIBH) in ultra-hypofractionat...
2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdf
Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdf
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
Psychedelic Retreat Portugal - Escape to Lighthouse Retreats for an unforgett...
Psychedelic Retreat Portugal - Escape to Lighthouse Retreats for an unforgett...
Friendly Massage in Ajman - Malayali Kerala Spa Ajman
Friendly Massage in Ajman - Malayali Kerala Spa Ajman
MANAGING CRITICAL ILL COVID IN ICU.ppt
- 1. MANAGING CRITICAL ILL COVID IN ICU DR. RAZIMAN BIN ABDUL RAZAK PAKAR ANESTHESIOLOGI JABATAN ANESTHESIOGI & UNIT RAWATAN RAPI HOSPITAL AMPANG
- 3. DEFINITION CRITICAL ILL PATIENT IN ICU COVID 19
- 5. HOSP AMPANG: SAPS II (43.7/ 42.0) SOFA (7.4/7.0)
- 8. HOSP AMPANG MORTALITY RATE (34.1%/ 43.5%)
- 9. COVID-19 • Covid-19 is an infectious disease causes by a newly discovered strain of coronavirus, a type of virus known to cause respiratory infections in human. • This new strain was unknown before December 2019, when an outbreak of a pneumonia of unidentified cause emerged in Wuhan, China. • The first case of COVID-19 in Malaysia was detected on 24 January 2020
- 10. • SARS- 2003 • H1N1- 2009 • AVIAN INFLUENZA A (H7N9)- 2014 • MERS-COV- 2012 (2018 MALAYSIA) • COVID-19- 2020 MALAYSIA
- 14. MANAGEMENT COVID • Same management as severe respiratory illness (SARI)/ ARDS except more precaution- full PPE
- 15. • Intubation box • Video laryngoscope
- 16. Mx- ARDS Guidelines 1. Lungs Protection (Protective Lungs Strategy) • Low Tidal Volume (6ml/kg) • Low Plateau Pressure (<30cmH2O) • Optimal PEEP 2. Recruitment Manoeuvre • Open the lungs and keep it open (escalating and deescalating to get an optimal PEEP)
- 17. 3. Ventilator Strategy • APRV • HFOV • Lungs dialysis (ECMO)
- 18. 4. Supportive Strategy • High sedation (RASS -4) • Paralysed/ Muscle relaxant • Prone position • Conservative fluid therapy 5. Role of NIV? • COAD • APO - Buy time, but don’t delay (can masking sx) 6. Close/continuous Monitoring - Oxygenation, ventilation, hemodynamic, hydration
- 19. CPR COVID
- 22. SUMMARY • Patient Covid with severe respiratory sx carries high mortality rate • Underlying comorbid+ elderly age+ other organ impairment/ failure added more mortality risk • Management SARI/ COVID can follow ARDS/ ALS guidelines with extra precautions to the frontliners.(full PPE) • Important to close monitoring CVS, Resp, Renal.
- 23. THANK YOU